Skip to main content
Log in

Increased theophylline clearance in asthmatic patients due to terbutaline

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetic mechanism of the theophylline-terbutaline interaction has been studied. Sustained release theophylline 200–400 mg b.d. was given with placebo or terbutaline 2.5 mg t.d.s. to six adult asthmatic patients.

Terbutaline decreased the serum trough theophylline levels from 8.1 to 7.3 µg/ml, improved daily the clinical score from 1.51 to 1.26 and increased the peak expiratory flow rate from 316 to 370 l/min. In a single dose study following the chronic therapy, it was shown that there was no change in the peak theophylline concentration or in the timing of the peak, but the t1/2 was reduced from 9.0 to 7.5 h, and the systemic clearance was increased from 20.2 to 24.8 ml·h−1·kg−1.

Thus, terbutaline reduced the serum theophylline concentration by increasing its systemic clearance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jenne JW (1981) A critique of dosing strategies for beta-2-adrenergic agents and theophylline. Lung 159: 295–314

    Google Scholar 

  2. Wolfe JD, Tashkin DP, Calvarese B, Simmons M (1978) Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients. N Engl J Med 298: 363–367

    Google Scholar 

  3. Madsen SM, Ribel U (1981) Pharmacokinetics of terbutaline and theophylline in guinea pigs when administered simultaneously. Acta Pharmacol Toxicol 48: 13–20

    Google Scholar 

  4. Hemstreet MP, Miles MV, Rutland RO (1982) Effect of intravenous isoproterenol on theophylline kinetics. J Allergy Clin Immunol 69: 360–364

    Google Scholar 

  5. Danziger Y, Garty M, Volwitz B, Ilfeld A, Varsano I, Rosenfeld JB (1985) Reduction of serum theophylline levels by terbutaline in children with asthma. Clin Pharmacol Ther 37: 469–471

    Google Scholar 

  6. Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York, pp 3–6

    Google Scholar 

  7. O'Rourke PP, Crone RK (1984) Effects of oral theophylline and oral salbutamol in treatment of asthma. Arch Dis Child 57: 674–676

    Google Scholar 

  8. Dawson KP, Ferusson DM (1982) Effects of oral theophylline and oral salbutamol in treatment of asthma. Arch Dis Child 57: 674–676

    Google Scholar 

  9. Godard PH, Selles JPH, Bres J, Terral C, Brun S, Bousquet J, Michel FB (1981) Influence d'un betamimetique sur les parametres pharmacocinetiques de la theophylline. Rev Fr Allerg Immunol Clin 21: 180

    Google Scholar 

  10. Sindow J, Stephens M, Self T, Stewart C, Bobo L, Pieper JA (1987) Acute effects of short-term subcutaneous terbutaline on theophylline disposition. Eur J Clin Pharmacol 32: 191–193

    Google Scholar 

  11. Richardson PDI, Withrington PG (1977) The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Br J Pharmacol 60: 239–249

    Google Scholar 

  12. Onrot J, Shaheen O, Biaggioni I, Goldberg MR, Feely J, Wilkinson GR, Hollister AS, Robertson D (1986) Reduction of liver plasma flow by caffeine and theophylline. Clin Pharmacol Ther 40: 506–510

    Google Scholar 

  13. Conrad KA; Nyman DW (1980) Effects of metaprolol and propranolol on theophylline elimination. Clin Pharmacol Ther 28: 463–467

    Google Scholar 

  14. Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267–293

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garty, M., Paul-Keslin, L., Ilfeld, D.N. et al. Increased theophylline clearance in asthmatic patients due to terbutaline. Eur J Clin Pharmacol 36, 25–28 (1989). https://doi.org/10.1007/BF00561018

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561018

Key words

Navigation